Physician profile
Kellen Stromberg
NPI 1194089987
$1,279.50
in general payments reported to CMS, 2019-2025
11 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $241 · 2021: $67.68 · 2022: $130 · 2023: $122 · 2024: $246 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $506.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $301.75 | 2024-2025 | Inspire |
| Livanova USA, INC. | $257.98 | 2019-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Intersect Ent, INC. | $234.62 | 2019-2020 | |
| Olympus America INC. | $122.27 | 2019-2022 | |
| Medtronic, INC. | $105.90 | 2023-2024 | N/A, Pteye Parathyroid Detection System |
| E.R. Squibb & Sons, L.L.C. | $78.36 | 2019 | |
| Stryker Corporation | $61.83 | 2020-2022 | |
| Genzyme Corporation | $49.24 | 2023-2025 | |
| Aerin Medical INC. | $32.58 | 2025 | |
| Phadia US INC. | $17.86 | 2022 | |
| Smith+Nephew, INC. | $17.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellen Stromberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.